Science Board Investigates How FDA Has Responded To Critical 2007 Report
This article was originally published in The Gray Sheet
Executive Summary
A subcommittee is evaluating progress the agency has made in regulatory science since the 2007 report, “FDA Science and Mission at Risk,” was issued, while identifying future needs.